| Hans-Günter Meyer-Thompson | International
USA. DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access
USA. DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access
The Drug Enforcement Administration (DEA), together with the Department of Health and Human Services (HHS), finalized telemedicine flexibility regulations for the prescribing of medications for opioid use disorder, including buprenorphine. (SAMHSA / DEA, USA, 17.01.2025)